Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-114.45M
↓ 152% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-45.44M
Historical baseline
PeriodValueYoY Change
TTM$-114.45M-9.8%
2024$-104.24M-25.2%
2023$-83.23M-115.8%
2022$-38.58M-56.5%
2021$-24.65M-165.8%
2020$-9.27M+60.4%
2019$-23.43M-106.7%
2018$-11.34M-5229.9%
2017$221000.00-